Search Results for "Posture-D"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Posture-D. Results 1 to 10 of 19 total matches.
See also: calcium, vitamin D

Calcium Supplements

   
The Medical Letter on Drugs and Therapeutics • Apr 03, 2000  (Issue 1075)
Posture-D (Selfcare) 600 125 2 5.99 1. Needed to provide 1,000 mg elemental calcium daily. 2. Retail ...
Claims for the superiority of various calcium supplements are now appearing on television and in the print media. A high calcium intake combined with vitamin D can increase bone density and reduce the incidence of fractures in older women and probably also in men.
Med Lett Drugs Ther. 2000 Apr 3;42(1075):29-31 |  Show IntroductionHide Introduction

Choice of an Antipsychotic

   
The Medical Letter on Drugs and Therapeutics • Dec 22, 2003  (Issue 1172)
Publication Vol. 45 (Issue 1172) December 22, 2003 EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna ...
A recent supplement to the Journal of Clinical Psychiatry, titled "The Expert Consensus Guideline Series: Optimizing Pharmacologic Treatment of Psychotic Disorders," concluded that most experts endorsed use of second-generation (atypical) antipsychotics rather than first-generation drugs, with risperidone (Risperdal - Janssen) the top choice for first episodes, multiple episodes or switches from another drug (JM Kane et al, J Clin Psychiatry 2003; 64 suppl 12:5). The supplement was sponsored by Janssen.
Med Lett Drugs Ther. 2003 Dec 22;45(1172):102-4 |  Show IntroductionHide Introduction

Drugs for Psychotic Disorders

   
The Medical Letter on Drugs and Therapeutics • Dec 19, 2016  (Issue 1510)
bid 200 mg bid $367.80 Fluphenazine3 – generic 1, 2.5, 5, 10 mg tabs; 2.5-10 mg divided 10 mg once/d ...
Oral antipsychotic drugs used for treatment of schizophrenia, schizoaffective disorder, delusional disorder, and other manifestations of psychosis or mania are listed in Table 1. Parenteral antipsychotic drugs used for treatment of these disorders are listed in Table 2.
Med Lett Drugs Ther. 2016 Dec 19;58(1510):160-4 |  Show IntroductionHide Introduction

Quetiapine for Schizophrenia

   
The Medical Letter on Drugs and Therapeutics • Dec 19, 1997  (Issue 1016)
) has a greater affinity for blocking serotonin 5HT 2 than dopamine D 2 receptors. Quetiapine also ...
Quetiapine (Seroquel - Zeneca), a dibenzothiazepine derivative, has been approved by the FDA for treatment of schizophrenia and other psychotic disorders. It is a new addition to the 'atypical' antipsychotics, which include olanzapine (Zyprexa - Medical Letter, 39:5, 1997), risperidone (Risperdal) and clozapine (Clozaril). Atypical antipsychotic drugs generally are less likely to cause extrapyramidal symptoms than older drugs such as haloperidol (Haldol, and others) or the phenothiazines.
Med Lett Drugs Ther. 1997 Dec 19;39(1016):117-8 |  Show IntroductionHide Introduction

Aerosolized Deoxyribonuclease for Cystic Fibrosis

   
The Medical Letter on Drugs and Therapeutics • Apr 15, 1994  (Issue 920)
includes postural drainage and systemic and aerosolized bronchodilators. Antibiotics are prescribed ...
Recombinant human deoxyribonuclease I (rhDNase; dornase alfa; Pulmozyme - Genentech), an enzyme that hydrolyzes extracellular DNA, is now available as a purified solution to decrease the viscosity of sputum in patients with cystic fibrosis. It requires a nebulizer to produce an aerosol mist for inhalation.
Med Lett Drugs Ther. 1994 Apr 15;36(920):34-5 |  Show IntroductionHide Introduction

Olanzapine for Schizophrenia

   
The Medical Letter on Drugs and Therapeutics • Jan 19, 1997  (Issue 992)
lan’ za peen) is unknown. The drug binds to serotonin type 2, 3 and 6, dopamine D 1 ,D 2 and D 4 ...
Olanzapine (Zyprexa - Lilly), a thienobenzodiazepine that structurally resembles and binds to many of the same receptors as clozapine (Clozaril), is now available in the USA for treatment of schizophrenia and other psychotic disorders.
Med Lett Drugs Ther. 1997 Jan 19;39(992):5-6 |  Show IntroductionHide Introduction

Formula Diets for Obesity

   
The Medical Letter on Drugs and Therapeutics • Mar 10, 1989  (Issue 787)
fatty acids. SOME DIET FORMULAS Product kcal/d Protein (g) Carbohydrates (g) Fat (g) Cost 1 HMR 500 ...
Liquid diets for weight reduction, once discredited because of their adverse effects, are becoming popular again. Now, formula diets are available through physicians or hospitals as part of a packaged weight-reduction program that includes nutrition education and modification of eating and exercise habits. Three widely used programs are Optifast (Sandoz), Medifast (Nutrition Institute of Maryland, 1840 York Road, Timonium, MD 21093) and HMR (Health Management Resources, 59 Temple Place, Boston, MA 02111).
Med Lett Drugs Ther. 1989 Mar 10;31(787):22-3 |  Show IntroductionHide Introduction

Nefazodone for Depression

   
The Medical Letter on Drugs and Therapeutics • Apr 14, 1995  (Issue 946)
outpatients with major depression found nefazodone, 50 to 300 mg b.i.d. (mean 396 mg/day), as effective ...
Nefazodone (Serzone - Bristol-Myers Squibb) was recently approved by the US Food and Drug Administration for treatment of depression. A phenylpiperazine, nefazodone is chemically related to trazodone (Desyrel, and others).
Med Lett Drugs Ther. 1995 Apr 14;37(946):33-5 |  Show IntroductionHide Introduction

Silodosin (Rapaflo) for Benign Prostatic Hyperplasia

   
The Medical Letter on Drugs and Therapeutics • Jan 12, 2009  (Issue 1303)
relaxation of vascular tone, postural hypotension and syncope. The selective alpha 1a antagonism ...
Silodosin (Rapaflo - Watson Pharmaceuticals), an alpha1a-adrenoreceptor selective antagonist, has been approved by the FDA for treatment of benign prostatic hyperplasia (BPH). Some medications for BPH are listed in the table on page 4. Alpha1 blockers are commonly used with 5a-reductase inhibitors such as finasteride, which can shrink the size of the prostate, but may take months to do so.
Med Lett Drugs Ther. 2009 Jan 12;51(1303):3-4 |  Show IntroductionHide Introduction

Deep Brain Stimulation for Parkinson's Disease

   
The Medical Letter on Drugs and Therapeutics • Apr 06, 2009  (Issue 1309)
, such as dysarthria, postural imbalance, freezing of gait and cognitive problems, do not improve with the procedure ...
Deep brain stimulation (DBS) is increasingly used to treat advanced Parkinson's disease (PD), but few controlled clinical trials have been published. New evidence from a large controlled study has recently become available.
Med Lett Drugs Ther. 2009 Apr 6;51(1309):26-7 |  Show IntroductionHide Introduction